How does Femmeola 150mg Tablet work?

Femmeola 150mg Tablet contains olaparib, a PARP inhibitor. It blocks the important PARP enzyme that is responsible for cancer cell growth and proliferation. As a result, its blockage inhibits cancer growth.

What is the composition of Femmeola 150mg Tablet?

The composition of Femmeola 150mg Tablet is Olaparib.

How to store Femmeola 150mg Tablet?

Store Femmeola 150mg Tablet at room temperature , preferably below 30 degree celcius. Kept it in an original container, tightly closed, protect it from direct moisture and light. Keep it out of reach of children and pets.

What are the common side effects of Femmeola 150mg Tablet?

The common side effects of Femmeola 150mg Tabletare Diarrhea, Insomnia, Nausea, Weakness, Rashes, Depression, Dizziness, Cough, Fever etc.

Buy Femmeola 150mg Tablet Online: Price, Uses, and Side Effects

Name: Femmeola 150mg Tablet
Brand: Femmeola
Price: 12000 INR
Availability: InStock
Rating: 4.57 (7 reviews)

Description

Femmeola 150mg Tablet is an anticancer medication prescribed by the doctor to treat ovarian, breast, pancreatic, and prostate cancers, particularly in patients with certain genetic mutations like BRCA.

Femmeola 150mg Tablet contains olaparib that inhibits cancer cell growth and proliferation.

Uses

Ovarian, Breast, Pancreatic, and Prostate Cancers with Genetic Mutations

Side Effects

Femmeola 150mg Tablet is a target therapy based medication. Immediately consult to your doctor, if side effects persist for a longer length of time.

Constipation
Reduced Appetite
Headache
Vomiting
Sweating
Fatigue
Taste Change
Body Ache
High Blood Pressure
Mouth Sore
Risk of Infection

Blood Clots
Heart Problems
Neurological Issues

How To Use

Femmeola 150mg Tablet containing is taken orally. Tablet is swallowed as it is with the help of water. It can be taken after or before food consumption.
Avoid crushing, chewing, breaking or biting of tablet to maintain its efficacy. For more personalized assistance and exact dosage, talk to your doctor about the same.

How It Works

Femmeola 150mg Tablet (olaparib) prevents cancer cells by repairing single-strand DNA breaks by inhibiting PARP enzymes, mainly PARP1 and PARP2.
PARP suppression locks the enzyme on DNA in cancers with BRCA1/2 or other homologous recombination repair (HRR) abnormalities, triggering replication fork collapse into double-strand breaks that overburdened cells are unable to repair, resulting in synthetic lethality and apoptosis.

Safety Advice

Alcohol

It is generally advice to avoid alcohol consumption while taking Femmeola 150mg Tablet due to its negative impact on body as well as medication reaction. For more details, Consult your Doctor.

Pregnancy

Femmeola 150mg Tablet is not prescribed at the time of pregnancy. It causes harm to growing fetus. Consult your doctor in case of accidental pregnancy or any further risks.

Breast Feeding

In general there is no data related to Femmeola 150mg Tablet and its effect on breast feeding. But it is generally not advisable during the medication course. Consult your Doctor for more information.

Driving

It is advisable not to drive, as you may feel dizzy and can come across blurred vision after taking Femmeola 150mg Tablet

Kidney

Share your medical history details related to kidney cancer or any other disease with your doctor before taking Femmeola 150mg Tablet.

Liver

Notify your doctor about any liver disease or infection before starting Femmeola 150mg Tablet course.As it can cause serious liver damage

FAQs

The purpose of Femmeola 150mg Tablet is to treat ovarian, breast, pancreatic, and prostate cancers, particularly in patients with certain genetic mutations like BRCA.

References

Bochum, S., Berger, S., & Martens, U. M. (2018). Olaparib. Small molecules in oncology, 217-233.
Gou, R., Horikawa, N., & Kosaka, K. (2022). Olaparib-induced cutaneous side effects in a patient with recurrent ovarian cancer. BMJ Case Reports CP, 15(4), e249177. https://pubmed.ncbi.nlm.nih.gov/35444023/
Zhou, Y., Zhao, S., Wu, T., & Zhang, H. (2022). Comparison of adverse reactions caused by olaparib for different indications. Frontiers in pharmacology, 13, 968163. https://pmc.ncbi.nlm.nih.gov/articles/PMC9326361/
Che, H., Wang, L. W., Ye, X. Y., & He, X. (2025). Olaparib research update: Mechanism, structure and clinical trials. Medicinal Chemistry Research, 34(3), 535-548.

Femmeola 150mg Tablet

About The Product